BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25613139)

  • 1. Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.
    Stevens PR; Gawryluk JW; Hui L; Chen X; Geiger JD
    Curr HIV Res; 2014; 12(6):378-87. PubMed ID: 25613139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    Teodorof-Diedrich C; Spector SA
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective activity of pDING in response to HIV-1 Tat.
    Darbinian N; Khalili K; Amini S
    J Cell Physiol; 2014 Feb; 229(2):153-61. PubMed ID: 23955241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons.
    Langford D; Grigorian A; Hurford R; Adame A; Crews L; Masliah E
    J Neurovirol; 2004 Dec; 10(6):327-37. PubMed ID: 15765804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.
    Soliman ML; Geiger JD; Chen X
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):163-170. PubMed ID: 27629410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
    Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
    Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.
    Teodorof-Diedrich C; Spector SA
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketone bodies protection against HIV-1 Tat-induced neurotoxicity.
    Hui L; Chen X; Bhatt D; Geiger NH; Rosenberger TA; Haughey NJ; Masino SA; Geiger JD
    J Neurochem; 2012 Jul; 122(2):382-91. PubMed ID: 22524563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress.
    Kruman II; Nath A; Mattson MP
    Exp Neurol; 1998 Dec; 154(2):276-88. PubMed ID: 9878167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tat-NOL3 protects against hippocampal neuronal cell death induced by oxidative stress through the regulation of apoptotic pathways.
    Sohn EJ; Shin MJ; Eum WS; Kim DW; Yong JI; Ryu EJ; Park JH; Cho SB; Cha HJ; Kim SJ; Yeo HJ; Yeo EJ; Choi YJ; Im SK; Kweon HY; Kim DS; Yu YH; Cho SW; Park M; Park J; Cho YJ; Choi SY
    Int J Mol Med; 2016 Jul; 38(1):225-35. PubMed ID: 27221790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.
    Bertrand SJ; Aksenova MV; Mactutus CF; Booze RM
    Exp Neurol; 2013 Oct; 248():228-35. PubMed ID: 23811015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway.
    De Simone FI; Darbinian N; Amini S; Muniswamy M; White MK; Elrod JW; Datta PK; Langford D; Khalili K
    J Neuroimmune Pharmacol; 2016 Jun; 11(2):358-68. PubMed ID: 27032771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K/Akt and ERK MAPK pathways.
    Zhou F; Liu X; Gao L; Zhou X; Cao Q; Niu L; Wang J; Zuo D; Li X; Yang Y; Hu M; Yu Y; Tang R; Lee BH; Choi BW; Wang Y; Izumiya Y; Xue M; Zheng K; Gao D
    J Neuroinflammation; 2019 Apr; 16(1):71. PubMed ID: 30947729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.
    Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA
    J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exposure to ethanol potentiates human immunodeficiency virus type 1 Tat-induced Ca(2+) overload and neuronal death in cultured rat cortical neurons.
    Brailoiu E; Brailoiu GC; Mameli G; Dolei A; Sawaya BE; Dun NJ
    J Neurovirol; 2006 Feb; 12(1):17-24. PubMed ID: 16595370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis.
    Perry SW; Norman JP; Litzburg A; Zhang D; Dewhurst S; Gelbard HA
    J Immunol; 2005 Apr; 174(7):4333-44. PubMed ID: 15778398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages.
    Kang W; Marasco WA; Tong HI; Byron MM; Wu C; Shi Y; Sun S; Sun Y; Lu Y
    J Neuroinflammation; 2014 Nov; 11():195. PubMed ID: 25416164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload.
    Hui B; Li J; Geng MY
    J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endolysosomes in HIV-1 Tat-induced neurotoxicity.
    Hui L; Chen X; Haughey NJ; Geiger JD
    ASN Neuro; 2012 Jun; 4(4):243-52. PubMed ID: 22591512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.
    Samikkannu T; Atluri VS; Arias AY; Rao KV; Mulet CT; Jayant RD; Nair MP
    Curr HIV Res; 2014; 12(6):397-405. PubMed ID: 25613138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.